Nature Communications (Aug 2024)

TFEB activation hallmarks antigenic experience of B lymphocytes and directs germinal center fate decisions

  • Matthias Münchhalfen,
  • Richard Görg,
  • Michael Haberl,
  • Jens Löber,
  • Jakob Willenbrink,
  • Laura Schwarzt,
  • Charlotte Höltermann,
  • Christian Ickes,
  • Leonard Hammermann,
  • Jan Kus,
  • Björn Chapuy,
  • Andrea Ballabio,
  • Sybille D. Reichardt,
  • Alexander Flügel,
  • Niklas Engels,
  • Jürgen Wienands

DOI
https://doi.org/10.1038/s41467-024-51166-3
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 21

Abstract

Read online

Abstract Ligation of the B cell antigen receptor (BCR) initiates humoral immunity. However, BCR signaling without appropriate co-stimulation commits B cells to death rather than to differentiation into immune effector cells. How BCR activation depletes potentially autoreactive B cells while simultaneously primes for receiving rescue and differentiation signals from cognate T lymphocytes remains unknown. Here, we use a mass spectrometry-based proteomic approach to identify cytosolic/nuclear shuttling elements and uncover transcription factor EB (TFEB) as a central BCR-controlled rheostat that drives activation-induced apoptosis, and concurrently promotes the reception of co-stimulatory rescue signals by supporting B cell migration and antigen presentation. CD40 co-stimulation prevents TFEB-driven cell death, while enhancing and prolonging TFEB’s nuclear residency, which hallmarks antigenic experience also of memory B cells. In mice, TFEB shapes the transcriptional landscape of germinal center B cells. Within the germinal center, TFEB facilitates the dark zone entry of light-zone-residing centrocytes through regulation of chemokine receptors and, by balancing the expression of Bcl-2/BH3-only family members, integrates antigen-induced apoptosis with T cell-provided CD40 survival signals. Thus, TFEB reprograms antigen-primed germinal center B cells for cell fate decisions.